{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:37:32Z","timestamp":1762004252756},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.jhep.2010.03.020","type":"journal-article","created":{"date-parts":[[2010,5,26]],"date-time":"2010-05-26T09:07:07Z","timestamp":1274864827000},"page":"449-454","source":"Crossref","is-referenced-by-count":37,"title":["Lamivudine plus adefovir or entecavir for patients with chronic hepatitis B resistant to lamivudine and adefovir"],"prefix":"10.1016","volume":"53","author":[{"given":"Nae-Yun","family":"Heo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Suk","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han Chu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Hwa","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yung Sang","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong Jin","family":"Suh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2010.03.020_b0005","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jhep.2008.10.001","article-title":"EASL Clinical Practice Guidelines: management of chronic hepatitis B","volume":"50","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.03.020_b0010","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.cgh.2008.08.021","article-title":"A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update","volume":"6","author":"Keeffe","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2010.03.020_b0015","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.23190","article-title":"Chronic hepatitis B: update 2009","volume":"50","author":"Lok","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.03.020_b0020","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1177\/135965350601100614","article-title":"Hepatitis B virus replication and liver disease progression: the impact of antiviral therapy","volume":"11","author":"Liaw","year":"2006","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jhep.2010.03.020_b0025","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/hep.1840400418","article-title":"Clinical outcome of HBeAg-negative chronic hepatitis B in relation to virological response to lamivudine","volume":"40","author":"Di Marco","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.03.020_b0030","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/hep.20760","article-title":"Outcome of hepatitis B e antigen-negative chronic hepatitis B on long-term nucleos(t)ide analog therapy starting with lamivudine","volume":"42","author":"Papatheodoridis","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.03.020_b0035","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1053\/jhep.2000.16665","article-title":"Hepatitis B e antigen seroconversion after lamivudine therapy is not durable in patients with chronic hepatitis B in Korea","volume":"32","author":"Song","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.03.020_b0040","doi-asserted-by":"crossref","first-page":"S174","DOI":"10.1002\/hep.22900","article-title":"Antiviral resistance and hepatitis B therapy","volume":"49","author":"Ghany","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.03.020_b0045","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/hep.21698","article-title":"Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management","volume":"46","author":"Lok","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.03.020_b0050","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1053\/j.gastro.2003.09.033","article-title":"Long-term safety of lamivudine treatment in patients with chronic hepatitis B","volume":"125","author":"Lok","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2010.03.020_b0055","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/j.1440-1746.2004.03428.x","article-title":"Four years of lamivudine treatment in Chinese patients with chronic hepatitis B","volume":"19","author":"Chang","year":"2004","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2010.03.020_b0060","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/j.gastro.2003.10.051","article-title":"Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B","volume":"126","author":"Peters","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2010.03.020_b0065","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1542-3565(03)00312-4","article-title":"A treatment algorithm for the management of chronic hepatitis B virus infection in the United States","volume":"2","author":"Keeffe","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2010.03.020_b0070","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/hep.20110","article-title":"Chronic hepatitis B: update of recommendations","volume":"39","author":"Lok","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.03.020_b0075","first-page":"S3","article-title":"EASL International Consensus Conference on Hepatitis B, 13\u201314 September 2002, Geneva, Switzerland. Consensus statement (long version)","volume":"39","author":"de Franchis","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.03.020_b0080","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jhep.2005.10.018","article-title":"Virologic response and resistance to adefovir in patients with chronic hepatitis B","volume":"44","author":"Fung","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.03.020_b0085","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1002\/hep.21189","article-title":"Increased risk of adefovir resistance in patients with lamivudine-resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy","volume":"43","author":"Lee","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.03.020_b0090","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1136\/gut.2005.077099","article-title":"Resistance to adefovir dipivoxil in lamivudine resistant chronic hepatitis B patients treated with adefovir dipivoxil","volume":"55","author":"Yeon","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2010.03.020_b0095","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/hep.21290","article-title":"Evolution of multi-drug resistant hepatitis B virus during sequential therapy","volume":"44","author":"Yim","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.03.020_b0100","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/hep.23145","article-title":"Efficacy of entecavir in patients with chronic hepatitis B resistant to both lamivudine and adefovir or to lamivudine alone","volume":"50","author":"Shim","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.03.020_b0105","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.cgh.2007.05.004","article-title":"Report of an international workshop: roadmap for management of patients receiving oral therapy for chronic hepatitis B","volume":"5","author":"Keeffe","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2010.03.020_b0110","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1053\/jhep.2001.27563","article-title":"Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy","volume":"34","author":"Yuen","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.03.020_b0115","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2893.2007.00915.x","article-title":"Antiviral-resistant hepatitis B virus: can we prevent this monster from growing?","volume":"14","author":"Zoulim","year":"2007","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2010.03.020_b0120","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S1473-3099(09)70056-8","article-title":"Prevention and management of drug resistance for antihepatitis B treatment","volume":"9","author":"Yuen","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jhep.2010.03.020_b0125","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.jhep.2005.05.037","article-title":"Adefovir-resistant hepatitis B can be associated with viral rebound and hepatic decompensation","volume":"43","author":"Fung","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.03.020_b0130","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/hep.21534","article-title":"Adding-on versus switching to adefovir therapy in lamivudine-resistant HBeAg-negative chronic hepatitis B","volume":"45","author":"Rapti","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.03.020_b0135","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1053\/j.gastro.2007.08.079","article-title":"Low resistance to adefovir combined with lamivudine: a 3-year study of 145 lamivudine-resistant hepatitis B patients","volume":"133","author":"Lampertico","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2010.03.020_b0140","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jhep.2007.12.018","article-title":"Lamivudine-resistant chronic hepatitis B: an observational study on adefovir in monotherapy or in combination with lamivudine","volume":"48","author":"Gaia","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.03.020_b0145","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jhep.2008.02.019","article-title":"Low risk of adefovir resistance in lamivudine-resistant chronic hepatitis B patients treated with adefovir plus lamivudine combination therapy: two-year follow-up","volume":"48","author":"Yatsuji","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.03.020_b0150","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/hep.21513","article-title":"Chronic hepatitis B","volume":"45","author":"Lok","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.03.020_b0155","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/hep.20723","article-title":"Susceptibility to antivirals of a human HBV strain with mutations conferring resistance to both lamivudine and adefovir","volume":"41","author":"Brunelle","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.03.020_b0160","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.jhep.2003.09.022","article-title":"Selection of a hepatitis B virus strain resistant to adefovir in a liver transplantation patient","volume":"39","author":"Villeneuve","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.03.020_b0165","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jhep.2008.01.027","article-title":"Impact of hepatitis B virus rtA181V\/T mutants on hepatitis B treatment failure","volume":"48","author":"Villet","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.03.020_b0170","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1177\/135965350601100801","article-title":"Unusual selection of rtA181V HBV mutants cross-resistant to adefovir following prolonged lamivudine monotherapy: report of two cases","volume":"11","author":"Gerolami","year":"2006","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jhep.2010.03.020_b0175","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1053\/j.gastro.2005.06.055","article-title":"A dose-ranging study of the efficacy and tolerability of entecavir in lamivudine-refractory chronic hepatitis B patients","volume":"129","author":"Chang","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2010.03.020_b0180","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1053\/j.gastro.2006.04.007","article-title":"Entecavir for treatment of lamivudine-refractory, HBeAg-positive chronic hepatitis B","volume":"130","author":"Sherman","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2010.03.020_b0185","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1053\/jhep.2001.27834","article-title":"Hepatitis B e antigen-negative chronic hepatitis B","volume":"34","author":"Hadziyannis","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.03.020_b0190","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1056\/NEJMra0801644","article-title":"Hepatitis B virus infection","volume":"359","author":"Dienstag","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2010.03.020_b0195","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1053\/j.gastro.2006.09.020","article-title":"Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years","volume":"131","author":"Hadziyannis","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2010.03.020_b0200","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/hep.22634","article-title":"Complex dynamics of hepatitis B virus resistance to adefovir","volume":"49","author":"Pallier","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.03.020_b0205","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1177\/135965350701200309","article-title":"In vitro susceptibility of adefovir-associated hepatitis B virus polymerase mutations to other antiviral agents","volume":"12","author":"Qi","year":"2007","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jhep.2010.03.020_b0210","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jhep.2008.10.033","article-title":"Entecavir shows limited efficacy in HBeAg-positive hepatitis B patients with a partial virologic response to adefovir therapy","volume":"50","author":"Reijnders","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.03.020_b0215","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jhep.2007.09.020","article-title":"Tenofovir monotherapy is effective in hepatitis B patients with antiviral treatment failure to adefovir in the absence of adefovir-resistant mutations","volume":"48","author":"Tan","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.03.020_b0220","first-page":"436","article-title":"Treatment of patients with lamivudine-resistant and adefovir dipivoxil-resistant chronic hepatitis B virus infection: is tenofovir the answer?","volume":"56","author":"Trojan","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2010.03.020_b0225","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.23246","article-title":"Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside\/nucleotide analogues","volume":"51","author":"van Bommel","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.03.020_b0230","first-page":"749A","article-title":"Combination of entecavir and tenofovir as a rescue therapy is safe and highly efficient in cirrhotic HBV mono-infected patients with the history of multiple previous treatment failures","volume":"48","author":"Schollmeyer","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.03.020_b0235","first-page":"721A","article-title":"Switching to adefovir plus entecavir is effective and leads to strong viral suppression in HBV mono-infected patients failing sequential or combination therapy with lamivudine and adefovir","volume":"48","author":"Schollmeyer","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.03.020_b0240","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1478-3231.2008.01685.x","article-title":"Tenofovir plus lamivudine as rescue therapy for adefovir-resistant chronic hepatitis B in hepatitis B e antigen-positive patients with liver cirrhosis","volume":"28","author":"Choe","year":"2008","journal-title":"Liver Int"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827810004551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827810004551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T08:47:18Z","timestamp":1685609238000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827810004551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0168827810004551"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2010.03.020","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}